Medication info
Esmizent Sublingual Tablet (Standardized Lyophilized Consortia Extract)

Esmizent Sublingual Tablet (Standardized Lyophilized Consortia Extract)

Prescription medicationSublingual TabletOral
Ingredient · strength
Standardized Lyophyllized of Bacterial Lysate›50mg / 1 tablet
Manufacturer / importer
Schumitt Health Korea LLC
Appearance
Pale yellow tablets with brown specks and a peculiar smell
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 200511326 · Notified 2005.05.16

Summary

Main use
Treatment of recurrent upper and lower respiratory tract infections (such as bronchitis and sinusitis)
Who takes it
Adults
Adult dose
Adults: Take 1 tablet once daily by allowing it to dissolve under the tongue before meals. Administer for 10 days each month, followed by a 20-day treatment-free period, for 3 months.

Ingredients

Importer
Schumitt Health Korea LLC

Efficacy & effects

Treatment of recurrent upper and lower respiratory tract infections (such as bronchitis and sinusitis)

  • Recurrent upper respiratory infections
  • recurrent lower respiratory infections
  • chronic respiratory diseases
  • bronchitis
  • sinusitis
View approved original text

This medication is used for recurrent infections of the upper and lower respiratory tracts, particularly for chronic respiratory diseases such as bronchitis and sinusitis.

How to take

Adult dose

Adults: Take 1 tablet once daily by allowing it to dissolve under the tongue before meals. Administer for 10 days each month, followed by a 20-day treatment-free period, for 3 months.

Precautions

This medication should not be used by patients who are allergic to any of its components. Additionally, patients with acute gastroenteritis are advised against taking this medication. Mild gastrointestinal disturbances such as diarrhea, abdominal pain, and vomiting may occasionally occur when taking this medication. Rarely, allergic skin conditions such as itching or rashes may develop. Respiratory symptoms such as cough, difficulty breathing, or asthma may also occur. On the first day of taking this medication, symptoms of respiratory inflammation may slightly worsen, or mild fever, fatigue, or allergic reactions may occur. This medication should not be taken together with oral live vaccines for 2 weeks before and after administration. Caution is also advised as the effectiveness of this medication may be reduced during immunosuppressive therapy. It is safer not to take this medication during the first three months of pregnancy. Although toxicity has not been reported in animal studies, special caution should be exercised, especially in early pregnancy. This medication should be kept out of reach of children, and it is advisable not to transfer it to another container to maintain quality.

Side effects

Mild gastrointestinal disturbances, diarrhea, abdominal pain, vomiting, allergic skin disorders, itching, skin rash, cough, shortness of breath, asthma, mild exacerbation of respiratory inflammation, mild fever, fatigue, allergic reactions

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best stored at room temperature away from direct sunlight. This will preserve the effectiveness of the medication and prevent deterioration.

Appearance and packaging

Appearance

Pale yellow tablets with brown specks and a peculiar smell

Package unit

30 tablets (10 tablets/PTP x 3)

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.